Previous Close | 97.90 |
Open | 98.00 |
Bid | 97.25 x 200 |
Ask | 97.38 x 200 |
Day's Range | 96.55 - 98.07 |
52 Week Range | 75.93 - 104.07 |
Volume | |
Avg. Volume | 1,147,180 |
Market Cap | 19.341B |
Beta (5Y Monthly) | 0.97 |
PE Ratio (TTM) | 66.65 |
EPS (TTM) | 1.46 |
Earnings Date | May 30, 2024 |
Forward Dividend & Yield | 0.02 (0.02%) |
Ex-Dividend Date | Jul 26, 2023 |
1y Target Est | 108.36 |
SAN RAMON, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, will participate in the Jefferies Global Healthcare Conference on Wednesday, June 6, 2024. Brian Andrews, Executive Vice President, Chief Financial Officer & Treasurer, will represent the Company in a session scheduled at 1:30 PM ET. The webcast will be available to investors and other interested parties by accessing the CooperCompanies’ website at http://investor.coopercos
Aspira (AWH) delivered earnings and revenue surprises of -8.33% and 2.52%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
SAN RAMON, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, will participate in the William Blair Growth Stock Conference on Wednesday, June 5, 2024. Dan McBride, Executive Vice President & Chief Operating Officer, will represent the Company in a session scheduled at 11:00 AM ET. The webcast will be available to investors and other interested parties by accessing the CooperCompanies’ website at http://investor.coopercos.com. About C